FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003706075> ?p ?o ?g. }

• W2003706075 abstract "The inhaled corticosteroid (ICS) fluticasone propionate (fluticasone) and the long-acting β2-agonist (LABA) formoterol fumarate (formoterol) are being made available as a combination product (fluticasone/formoterol, flutiform ®) in a single aerosol inhaler. This 12-week, open-label, randomized, active-controlled, parallel-group, multicentre, phase 3 study compared the efficacy and safety of fluticasone/formoterol with the commercially available combination product fluticasone/salmeterol. Patients aged ≥ 18 years (N = 202) with mild-to-moderate–severe, persistent asthma for ≥ 6 months prior to screening were included in the study. After a screening phase (4–10 days), eligible patients were randomized 1:1 to receive fluticasone/formoterol or fluticasone/salmeterol during the 12-week treatment period. The primary objective was to demonstrate non-inferiority of fluticasone/formoterol versus fluticasone/salmeterol, measured by pre-dose forced expiratory volume in the first second (FEV1), at week 12. Fluticasone/formoterol was comparable to fluticasone/salmeterol for the primary efficacy endpoint, mean pre-dose FEV1 at week 12. The new combination was also comparable to fluticasone/salmeterol for change from baseline to week 12 in pre-dose FEV1, change from pre-dose FEV1 at baseline to 2-hour post-dose FEV1 at week 12 and discontinuations due to lack of efficacy. Importantly, fluticasone/formoterol was superior to fluticasone/salmeterol in time to onset of action throughout the duration of the study. The two treatments demonstrated similar results for various other secondary efficacy parameters, including other lung function tests, patient-reported outcomes, rescue medication use, asthma exacerbations and Asthma Quality of Life Questionnaire scores. Fluticasone/formoterol was well tolerated and had a good safety profile that was similar to fluticasone/salmeterol. The results of this study indicate that fluticasone/formoterol is as effective as fluticasone/salmeterol, and has a more rapid onset of action, reflecting the faster bronchodilatory effects of formoterol compared with those of salmeterol. If patients perceive the benefits of therapy with fluticasone/formoterol more rapidly than with fluticasone/salmeterol, this could have a positive impact on preference and adherence. ClinicalTrials.gov: NCT00476073" @default.
• W2003706075 created "2016-06-24" @default.
• W2003706075 creator A5019552605 @default.
• W2003706075 creator A5020540789 @default.
• W2003706075 creator A5020685991 @default.
• W2003706075 creator A5082981501 @default.
• W2003706075 date "2011-05-23" @default.
• W2003706075 modified "2023-10-10" @default.
• W2003706075 title "Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study" @default.
• W2003706075 cites W1931016737 @default.
• W2003706075 cites W1963885621 @default.
• W2003706075 cites W1974042832 @default.
• W2003706075 cites W1985171602 @default.
• W2003706075 cites W1986535116 @default.
• W2003706075 cites W1986839396 @default.
• W2003706075 cites W2041256289 @default.
• W2003706075 cites W2053351348 @default.
• W2003706075 cites W2062346210 @default.
• W2003706075 cites W2072039353 @default.
• W2003706075 cites W2076544702 @default.
• W2003706075 cites W2082690625 @default.
• W2003706075 cites W2088958539 @default.
• W2003706075 cites W2092648747 @default.
• W2003706075 cites W2097573524 @default.
• W2003706075 cites W2100197717 @default.
• W2003706075 cites W2106566051 @default.
• W2003706075 cites W2107060512 @default.
• W2003706075 cites W2109613186 @default.
• W2003706075 cites W2113634031 @default.
• W2003706075 cites W2113934803 @default.
• W2003706075 cites W2114686628 @default.
• W2003706075 cites W2136892596 @default.
• W2003706075 cites W2139099862 @default.
• W2003706075 cites W2161390117 @default.
• W2003706075 cites W2166915032 @default.
• W2003706075 cites W2171331726 @default.
• W2003706075 doi "https://doi.org/10.1186/1471-2466-11-28" @default.
• W2003706075 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3146950" @default.
• W2003706075 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21605396" @default.
• W2003706075 hasPublicationYear "2011" @default.
• W2003706075 type Work @default.
• W2003706075 sameAs 2003706075 @default.
• W2003706075 citedByCount "69" @default.
• W2003706075 countsByYear W20037060752012 @default.
• W2003706075 countsByYear W20037060752013 @default.
• W2003706075 countsByYear W20037060752014 @default.
• W2003706075 countsByYear W20037060752015 @default.
• W2003706075 countsByYear W20037060752016 @default.
• W2003706075 countsByYear W20037060752017 @default.
• W2003706075 countsByYear W20037060752018 @default.
• W2003706075 countsByYear W20037060752019 @default.
• W2003706075 countsByYear W20037060752020 @default.
• W2003706075 countsByYear W20037060752021 @default.
• W2003706075 countsByYear W20037060752022 @default.
• W2003706075 countsByYear W20037060752023 @default.
• W2003706075 crossrefType "journal-article" @default.
• W2003706075 hasAuthorship W2003706075A5019552605 @default.
• W2003706075 hasAuthorship W2003706075A5020540789 @default.
• W2003706075 hasAuthorship W2003706075A5020685991 @default.
• W2003706075 hasAuthorship W2003706075A5082981501 @default.
• W2003706075 hasBestOaLocation W20037060751 @default.
• W2003706075 hasConcept C126322002 @default.
• W2003706075 hasConcept C2776042228 @default.
• W2003706075 hasConcept C2776136866 @default.
• W2003706075 hasConcept C2776719499 @default.
• W2003706075 hasConcept C2779028295 @default.
• W2003706075 hasConcept C2779871671 @default.
• W2003706075 hasConcept C2780261241 @default.
• W2003706075 hasConcept C2781212218 @default.
• W2003706075 hasConcept C2909086917 @default.
• W2003706075 hasConcept C42219234 @default.
• W2003706075 hasConcept C71924100 @default.
• W2003706075 hasConceptScore W2003706075C126322002 @default.
• W2003706075 hasConceptScore W2003706075C2776042228 @default.
• W2003706075 hasConceptScore W2003706075C2776136866 @default.
• W2003706075 hasConceptScore W2003706075C2776719499 @default.
• W2003706075 hasConceptScore W2003706075C2779028295 @default.
• W2003706075 hasConceptScore W2003706075C2779871671 @default.
• W2003706075 hasConceptScore W2003706075C2780261241 @default.
• W2003706075 hasConceptScore W2003706075C2781212218 @default.
• W2003706075 hasConceptScore W2003706075C2909086917 @default.
• W2003706075 hasConceptScore W2003706075C42219234 @default.
• W2003706075 hasConceptScore W2003706075C71924100 @default.
• W2003706075 hasIssue "1" @default.
• W2003706075 hasLocation W20037060751 @default.
• W2003706075 hasLocation W20037060752 @default.
• W2003706075 hasLocation W20037060753 @default.
• W2003706075 hasLocation W20037060754 @default.
• W2003706075 hasOpenAccess W2003706075 @default.
• W2003706075 hasPrimaryLocation W20037060751 @default.
• W2003706075 hasRelatedWork W2003706075 @default.
• W2003706075 hasRelatedWork W2032558045 @default.
• W2003706075 hasRelatedWork W2057543685 @default.
• W2003706075 hasRelatedWork W2080945474 @default.
• W2003706075 hasRelatedWork W2086416159 @default.
• W2003706075 hasRelatedWork W2106890032 @default.
• W2003706075 hasRelatedWork W2154436876 @default.
• W2003706075 hasRelatedWork W2407210537 @default.
• W2003706075 hasRelatedWork W2621439852 @default.
• W2003706075 hasRelatedWork W2982865571 @default.

• next